More from the article...

... The PBMs generated more than $7.3 billion in excess revenue, with affiliated pharmacies receiving higher reimbursements than unaffiliated counterparts.

"The FTC staff's second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of lifesaving drugs, including medications to treat heart disease and cancer," said FTC Chair Lina Khan. ...

... imposed markups of hundreds to thousands of percent on critical drugs ...

Another example of corporations exploiting the needed healthcare of people for the profits of their wealthy owners?